Cvs Pharmacy #02904 | |
6354 N Orange Blossom Trl, Orlando, Florida 32810 | |
(407) 290-0366 |
Name | Cvs Pharmacy #02904 |
---|---|
Organization Name | Holiday Cvs Llc |
Location | 6354 N Orange Blossom Trl, Orlando, Florida 32810 |
Type | Pharmacy |
Phone | (407) 290-0366 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The importance of cleanrooms is currently in the spotlight as the global community awaits a vaccine for Covid-19.
To produce drugs sustainably and cheaply, anywhere you want. Whether in the middle of the jungle or even on Mars. A 'mini-factory' whereby sunlight can be captured to make chemical products.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preclinical data which demonstrate that its Notch1-specific monoclonal antibody is a highly potent inhibitor of Notch1 function in both in vitro and in vivo models. These data were presented today at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010 in Washington, D.C.
Pfizer announced today that marketing authorization applications for maraviroc will receive accelerated review in both the United States and Europe. Accelerated reviews are granted to potential medicines that, if approved, would represent significant improvements over current therapies.
AVEO Pharmaceuticals, Inc. today announced results from the Phase 1b portion of its Phase 1b/2 clinical study of ficlatuzumab in combination with gefitinib in Asian subjects with non-small cell lung cancer.
› Verified 1 days ago
NPI Number | 1932203841 |
Organization Name | HOLIDAY CVS LLC |
Doing Business As | CVS PHARMACY # 02904 |
Type | Pharmacy |
Address | 6354 N Orange Blossom Trl, Orlando, FL 32810 |
Phone Number | 407-290-0366 |
News Archive
The importance of cleanrooms is currently in the spotlight as the global community awaits a vaccine for Covid-19.
To produce drugs sustainably and cheaply, anywhere you want. Whether in the middle of the jungle or even on Mars. A 'mini-factory' whereby sunlight can be captured to make chemical products.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preclinical data which demonstrate that its Notch1-specific monoclonal antibody is a highly potent inhibitor of Notch1 function in both in vitro and in vivo models. These data were presented today at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010 in Washington, D.C.
Pfizer announced today that marketing authorization applications for maraviroc will receive accelerated review in both the United States and Europe. Accelerated reviews are granted to potential medicines that, if approved, would represent significant improvements over current therapies.
AVEO Pharmaceuticals, Inc. today announced results from the Phase 1b portion of its Phase 1b/2 clinical study of ficlatuzumab in combination with gefitinib in Asian subjects with non-small cell lung cancer.
› Verified 1 days ago
News Archive
The importance of cleanrooms is currently in the spotlight as the global community awaits a vaccine for Covid-19.
To produce drugs sustainably and cheaply, anywhere you want. Whether in the middle of the jungle or even on Mars. A 'mini-factory' whereby sunlight can be captured to make chemical products.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preclinical data which demonstrate that its Notch1-specific monoclonal antibody is a highly potent inhibitor of Notch1 function in both in vitro and in vivo models. These data were presented today at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010 in Washington, D.C.
Pfizer announced today that marketing authorization applications for maraviroc will receive accelerated review in both the United States and Europe. Accelerated reviews are granted to potential medicines that, if approved, would represent significant improvements over current therapies.
AVEO Pharmaceuticals, Inc. today announced results from the Phase 1b portion of its Phase 1b/2 clinical study of ficlatuzumab in combination with gefitinib in Asian subjects with non-small cell lung cancer.
› Verified 1 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3443 Parkway Center Ct, Orlando, Florida 32808 Phone: (407) 297-0100 | |
Florida Mobility Products Type: DME Supplier - Oxygen Equipment & Supplies Location: 8451 S John Young Pkwy, Orlando, Florida 32819 Phone: (407) 363-3535 | |
Publix Pharmacy #1131 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 400 E Central Blvd, Orlando, Florida 32801 Phone: (407) 872-7207 | |
Publix Pharmacy #1338 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 10250 Curry Ford Rd, Orlando, Florida 32825 Phone: (407) 207-6112 | |
Publix Pharmacy #0692 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4402 Curry Ford Rd, Orlando, Florida 32812 Phone: (407) 282-8128 |